These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6303226)

  • 1. An immunofluorescence complement-fixation test for detection of human papilloma viruses in various warts and wartlike lesions of epidermodysplasia verruciformis.
    Chorzelski T; Jarzabek-Chorzelska M; Jabłońska S; Orth G; Rzesa G
    Arch Dermatol Res; 1983; 275(1):53-7. PubMed ID: 6303226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological studies in epidermodysplasia verruciformis.
    Jablonska S; Orth G; Jarzabek-Chorzelska M; Rzesa G; Obalek S; Glinski W; Favre M; Croissant O
    Bull Cancer; 1978; 65(2):183-90. PubMed ID: 212145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New developments relating to papillomaviruses].
    Jablonska S; Orth G; Jarzabek-Chorzelska M; Obalek S; Rzesa G; Croissant O; Favre M
    Hautarzt; 1979 Aug; 30(8):411-7. PubMed ID: 229087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis.
    Orth G; Jablonska S; Favre M; Croissant O; Jarzabek-Chorzelska M; Rzesa G
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1537-41. PubMed ID: 206906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific cell-mediated immunity in patients with epidermodysplasia verruciformis and plane warts.
    Haftek M; Jabłonska S; Orth G
    Dermatologica; 1985; 170(5):213-20. PubMed ID: 2989014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus 8-L1 immune serum: a new diagnostic possibility for Epidermodysplasia verruciformis-specific HPVs.
    Steger G; Jarzabek-Chorzelska M; Jablonska S; Pfister H
    J Invest Dermatol; 1988 Jul; 91(1):76-81. PubMed ID: 2838555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV3 or HPV3-related types in immunosuppressed patients.
    Obalek S; Favre M; Szymanczyk J; Misiewicz J; Jablonska S; Orth G
    J Invest Dermatol; 1992 Jun; 98(6):936-41. PubMed ID: 1317396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to human papillomavirus type 5 are generated in epidermal repair processes.
    Favre M; Majewski S; Noszczyk B; Maienfisch F; Pura A; Orth G; Jablonska S
    J Invest Dermatol; 2000 Mar; 114(3):403-7. PubMed ID: 10692096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an immunologically distinct papillomavirus from lesions of epidermodysplasia verruciformis.
    Pass F; Reissig M; Shah KV; Eisinger M; Orth G
    J Natl Cancer Inst; 1977 Oct; 59(4):1107-12. PubMed ID: 71354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermodysplasia verruciformis versus disseminated verrucae planae: is epidermodysplasia verruciformis a generalized infection with wart virus?
    Jablonska S; Orth G; Jarzabek-Chorzelska M; Rzesa G; Obałek S; Glinski W; Favre M; Croissant O
    J Invest Dermatol; 1979 Mar; 72(3):114-9. PubMed ID: 217936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vivo study of cell-mediated immunity in human warts. Preliminary results.
    Thivolet J; Hegazy MR; Viac J; Chardonnet Y
    Acta Derm Venereol; 1977; 57(4):317-9. PubMed ID: 70923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune reactions in epidermodysplasia verruciformis.
    Pyrhönen S; Jablonska S; Obałek S; Kuismanen E
    Br J Dermatol; 1980 Mar; 102(3):247-54. PubMed ID: 6245674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus infections in a group of renal transplant recipients.
    Rüdlinger R; Smith IW; Bunney MH; Hunter JA
    Br J Dermatol; 1986 Dec; 115(6):681-92. PubMed ID: 3026431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and typing of human papillomaviruses in mucosal and cutaneous biopsies from immunosuppressed and immunocompetent patients and patients with epidermodysplasia verruciformis: a unified diagnostic approach.
    Surentheran T; Harwood CA; Spink PJ; Sinclair AL; Leigh IM; Proby CM; McGregor JM; Breuer J
    J Clin Pathol; 1998 Aug; 51(8):606-10. PubMed ID: 9828820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible vertical transmission of human papillomavirus genotypes associated with epidermodysplasia verruciformis.
    Favre M; Majewski S; De Jesus N; Malejczyk M; Orth G; Jablonska S
    J Invest Dermatol; 1998 Aug; 111(2):333-6. PubMed ID: 9699739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermodysplasia verruciformis.
    Prystowsky SD; Herndon JH; Freeman RG; Boudreau C
    Am J Dis Child; 1976 Apr; 130(4):437-40. PubMed ID: 1266830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cell-mediated immunity to human papillomavirus type 1 (HPV-1) in human warts.
    Kienzler JL; Lemoine MT; Orth G; Jibard N; Blanc D; Laurent R; Agache P
    Br J Dermatol; 1983 Jun; 108(6):665-72. PubMed ID: 6305382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The virus of epidermodysplasia verruciformis: electron microscopic and fluorescent antibody studies.
    Yabe Y; Sadakane H
    J Invest Dermatol; 1975 Sep; 65(3):324-30. PubMed ID: 808576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology of human warts.
    Briggaman RA; Wheeler CE
    J Am Acad Dermatol; 1979 Oct; 1(4):297-304. PubMed ID: 229134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermodysplasia verruciformis induced by a new human papillomavirus (HPV-8). Report of a case without immune dysfunction. Effect of treatment with an aromatic retinoid.
    Claudy AL; Touraine JL; Mitanne D
    Arch Dermatol Res; 1982; 274(3-4):213-9. PubMed ID: 6299205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.